Department of Community Health and Health, School of Public Health and Health Professions, University at Buffalo, 3435 Main Street, 305 Kimball Tower, Buffalo, NY, 14214, USA.
Department of Psychiatry and Medicine, University of Rochester, 601 Elmwood Avenue, Rochester, NY, 14642, USA.
Subst Abuse Treat Prev Policy. 2020 Nov 23;15(1):89. doi: 10.1186/s13011-020-00331-0.
BACKGROUND: Women's rise in opioid use disorder has increased their presence in the criminal justice system and related risk behaviors for HIV infection. Although pre-exposure prophylaxis (PrEP) is an effective biomedical HIV prevention treatment, uptake among this high-risk population has been particularly low. Considerably little is known about the interplay between justice-involved women with opioid use disorder and HIV prevention. The aim of this study was to explore PrEP knowledge, attitudes, and perceptions for personal and partner use among women participants in the nation's first ever opioid intervention court program. METHODS: The authors conducted semi-structured, in-depth interviews with 31 women recruited from an Opioid Intervention Court, a recent fast-track treatment response to combat overdose deaths. We utilized a consensual qualitative research approach to explore attitudes, perceptions, and preferences about PrEP from women at risk for HIV transmission via sexual and drug-related behavior and used thematic analysis methods to code and interpret the data. RESULTS: PrEP interest and motivation were impacted by various factors influencing the decision to consider PrEP initiation or comfort with partner use. Three primary themes emerged: HIV risk perceptions, barriers and facilitators to personal PrEP utilization, and perspectives on PrEP use by sexual partners. CONCLUSIONS: Findings suggest courts may provide a venue to offer women PrEP education and HIV risk assessments. Study findings inform public health, substance use, and criminal justice research and practice with justice-involved participants experiencing opioid use disorder on the development of gender-specific PrEP interventions with the ultimate goal of reducing HIV incidence.
背景:女性阿片类药物使用障碍的增加使她们更多地出现在刑事司法系统中,并增加了感染艾滋病毒的相关风险行为。虽然暴露前预防(PrEP)是一种有效的预防艾滋病毒的生物医学方法,但在这一高危人群中的使用率特别低。人们对涉及阿片类药物使用障碍和艾滋病毒预防的女性在司法系统中的相互作用知之甚少。本研究旨在探索全国首个阿片类药物干预法庭项目中女性参与者对个人和伴侣使用 PrEP 的知识、态度和看法。
方法:作者对 31 名从阿片类药物干预法庭招募的女性进行了半结构式深入访谈,阿片类药物干预法庭是一种最近推出的快速治疗方案,以应对过量死亡。我们采用共识定性研究方法来探索处于通过性和药物相关行为传播艾滋病毒风险的女性对 PrEP 的态度、看法和偏好,并使用主题分析方法对数据进行编码和解释。
结果:各种因素影响着决定是否考虑启动 PrEP 或对伴侣使用 PrEP 的接受程度,从而影响 PrEP 的兴趣和动机。出现了三个主要主题:艾滋病毒风险认知、个人使用 PrEP 的障碍和促进因素,以及对性伴侣使用 PrEP 的看法。
结论:研究结果表明,法庭可能为提供女性 PrEP 教育和艾滋病毒风险评估提供了一个场所。研究结果为公共卫生、药物使用和刑事司法领域的研究和实践提供了信息,为涉及阿片类药物使用障碍的司法参与女性制定特定性别的 PrEP 干预措施提供了信息,最终目标是降低艾滋病毒发病率。
AIDS Patient Care STDS. 2018-10-11
Princ Pract Clin Res. 2024-4-16
Cad Saude Publica. 2023
MMWR Morb Mortal Wkly Rep. 2020-3-20
J Int Assoc Provid AIDS Care. 2020
MMWR Morb Mortal Wkly Rep. 2019-12-6